Literature DB >> 1370348

Infectious enveloped RNA virus antigenic chimeras.

S D London1, A L Schmaljohn, J M Dalrymple, C M Rice.   

Abstract

Random insertion mutagenesis has been used to construct infectious Sindbis virus structural protein chimeras containing a neutralization epitope from a heterologous virus, Rift Valley fever virus. Insertion sites, permissive for recovery of chimeric viruses with growth properties similar to the parental virus, were found in the virion E2 glycoprotein and the secreted E3 glycoprotein. For the E2 chimeras, the epitope was expressed on the virion surface and stimulated a partially protective immune response to Rift Valley fever virus infection in vivo. Besides providing a possible approach for developing live attenuated vaccine viruses, insertion of peptide ligands into virion surface proteins may ultimately allow targeting of virus infection to specific cell types.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370348      PMCID: PMC48205          DOI: 10.1073/pnas.89.1.207

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus.

Authors:  M S Collett; A F Purchio; K Keegan; S Frazier; W Hays; D K Anderson; M D Parker; C Schmaljohn; J Schmidt; J M Dalrymple
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

2.  Mutagenesis by random linker insertion into the lamB gene of Escherichia coli K12.

Authors:  J C Boulain; A Charbit; M Hofnung
Journal:  Mol Gen Genet       Date:  1986-11

3.  Gene therapy. Intracellular immunization.

Authors:  D Baltimore
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

4.  Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants.

Authors:  C M Rice; R Levis; J H Strauss; H V Huang
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 5.  Immunotoxins.

Authors:  I Pastan; M C Willingham; D J FitzGerald
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

6.  Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro.

Authors:  J M Polo; N L Davis; C M Rice; H V Huang; R E Johnston
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein.

Authors:  A L Schmaljohn; K M Kokubun; G A Cole
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

8.  Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis.

Authors:  A L Schmaljohn; E D Johnson; J M Dalrymple; G A Cole
Journal:  Nature       Date:  1982-05-06       Impact factor: 49.962

9.  Complete nucleotide sequence of the genomic RNA of Sindbis virus.

Authors:  E G Strauss; C M Rice; J H Strauss
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

10.  Sindbis virus: an efficient, broad host range vector for gene expression in animal cells.

Authors:  C Xiong; R Levis; P Shen; S Schlesinger; C M Rice; H V Huang
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

View more
  21 in total

1.  Functional characterization of the Sindbis virus E2 glycoprotein by transposon linker-insertion mutagenesis.

Authors:  Chanakha K Navaratnarajah; Richard J Kuhn
Journal:  Virology       Date:  2007-02-15       Impact factor: 3.616

2.  Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.

Authors:  M Tsuji; C C Bergmann; Y Takita-Sonoda; K Murata; E G Rodrigues; R S Nussenzweig; F Zavala
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function.

Authors:  I Tubulekas; P Liljeström
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 4.  Alphavirus-based expression vectors: strategies and applications.

Authors:  I Frolov; T A Hoffman; B M Prágai; S A Dryga; H V Huang; S Schlesinger; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  RNA viruses as vectors for the expression of heterologous proteins.

Authors:  S Schlesinger
Journal:  Mol Biotechnol       Date:  1995-04       Impact factor: 2.695

Review 6.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

7.  Sindbis virus attachment: isolation and characterization of mutants with impaired binding to vertebrate cells.

Authors:  J Dubuisson; C M Rice
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

Authors:  X Zhou; P Berglund; H Zhao; P Liljeström; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

Authors:  N L Davis; K W Brown; R E Johnston
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Molecular targeting of intracellular compartments specifically in cancer cells.

Authors:  Hetal Pandya; Denise M Gibo; Waldemar Debinski
Journal:  Genes Cancer       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.